Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

Juergen Wolf, Tobias R. Overbeck, Ji-Youn Han, Maximilian Hochmair, Filippo de Marinis, Kadoaki Ohashi, Egbert F. Smit, Danielle Power, Edward B. Garon, Harry J. M. Groen, Daniel Shao-Weng Tan, Maeve Waldron-Lynch, Sylvie Le Mouhaer, Ngozi Nwana, Monica Giovannini, Rebecca Suk Heist


Originele taal-2English
Aantal pagina's2
TijdschriftJournal of Clinical Oncology
Nummer van het tijdschrift15
StatusPublished - 20-mei-2020

Citeer dit